Musk aims for Neuralink ‘high-volume’ brain implant production in 2026

Elon Musk has recently announced that brain implant company Neuralink aims to enter "high-volume production” of brain-computer interface devices in 2026.

The prime motive behind this revelation is to transition from experimental clinical trials towards a scalable medical product. This shift aims to achieve a fully automated surgical procedure by 2026, according to Musk’s post on X.

According to Reuters, the implant is designed to provide assistance to people with conditions such as a spinal cord injury. It has been observed that the first patient has used it to play video games, surf the internet, and post on social media.

The company was efficiently working to begin human trials of its brain implant in 2024 after resolving concerns raised by the U.S. Food and Drug Administration, which initially withheld approval in 2022.

Neuralink reached a major milestone in September, announcing that 12 people globally with severe paralysis have received its brain implants to control digital and physical tools. This progress follows a successful $650 million funding round in June.

The recent shift transforms Neuralink from a research-focused startup into a large-scale medical manufacturer.

Furthermore, the company has designated 2026 as the year to begin high-volume production of its brain-computer interface devices.